Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient

Background/Aim: Hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in patients affected by hereditary bleeding disorders. HCV, as others RNA virus, exploit all possible mechanisms of genetic variation to ensure their survival, such as recombination and mutation.

In order to gain insight into the genetic variability of HCV virus strains circulating in hemophiliac patients, we have performed a phylogenetic analysis of HCV strains isolated from 10 patients with this kind of pathology.

Methods: Putative recombinant sequence was identified with the use of GARD program. Statistical support for the presence of a recombination event was done by the use of LARD program.

Results: A new intragenotypic recombinant strain (1b/1a) was detected in 1 out of the 10 hemophiliac patient studied.

The recombination event was located at position 388 of the HCV genome (relative to strain AF009606, sub-type 1a) corresponding to the core gene region.

Conclusion: Although recombination may not appear to be common among natural populations of HCV it should be considered as a possible mechanism for generating genetic diversity in hemophiliacs patients.

Author: Pilar MorenoMacarena AlvarezLilia LopezGonzalo MoratorioDidier CasaneMatias CastellsSilvia CastroJuan CristinaRodney Colina
Credits/Source: Virology Journal 2009, 6:203

Published on: 2009-11-18

Copyright by the authors listed above - made available via BioMedCentral (Open Access). Please make sure to read our disclaimer prior to contacting 7thSpace Interactive. To contact our editors, visit our online helpdesk. If you wish submit your own press release, click here.

Comments Page 1 of 1

Tony

Posted 920 days ago

...and I am sure novartis has the "solution"!!!

<1>

+ Add New Comment

Custom Search